HOTH icon

Hoth Therapeutics
HOTH

Overview Fund Trends Analyst Outlook Journalist POV
1.36 USD
--0.04
2.86%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
1.38
+0.02
1.47%
1 day
-2.86%
5 days
-2.16%
1 month
-16.05%
3 months
0.74%
6 months
51.28%
Year to date
76.6%
1 year
50.71%
5 years
-96.74%
10 years
-99.36%
 

About: Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Employees: 3

Healthcare Biotechnology
0
Funds holding %
of 7,502 funds
Explore Fund Trends
0
Analysts bullish %
of 1 analysts
See Analyst Outlook
0
Positive news %
of 4 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™